Suppr超能文献

为数据安全监测委员会成员开展培训:美国国立过敏与传染病研究所案例研究

Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study.

作者信息

Zuckerman Judith, van der Schalie Barbara, Cahill Kelly

机构信息

Office of Strategic Planning and Assessment, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA

Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

出版信息

Clin Trials. 2015 Dec;12(6):688-91. doi: 10.1177/1740774515591498. Epub 2015 Jul 7.

Abstract

BACKGROUND

Data Safety Monitoring Boards primarily review accumulating data on clinical trials and provide recommendations to sponsors on whether a protocol should continue as planned, be modified, or be terminated. Data Safety Monitoring Boards often provide their recommendations based upon accumulating data to which only their members are given access. Despite the substantial responsibilities assumed by Data Safety Monitoring Board members, there is limited information in the literature about the unique knowledge they must possess and, consequently, the training content needs that are required in order for them to fulfill their obligations.

PURPOSE

This article describes how the National Institute of Allergy and Infectious Diseases identified the knowledge that Data Safety Monitoring Board members should acquire and the computer-based training they developed to address the learning needs of the National Institute of Allergy and Infectious Diseases assembled Data Safety Monitoring Board members.

METHODS

The National Institute of Allergy and Infectious Diseases conducted a comprehensive literature search and interviewed Data Safety Monitoring Board subject matter experts, including Data Safety Monitoring Board members and chairs from academic institutions, pharmaceutical companies, and the National Institutes of Health to (1) assess whether Data Safety Monitoring Board training is an identified need, (2) evaluate whether Data Safety Monitoring Board training has been developed, and (3) formulate suitable learning objectives. Data Safety Monitoring Board training modules were developed based on the identified learning objectives identified from the interviews.

RESULTS

Three Data Safety Monitoring Board training modules were developed and formatted for web-based access, which is free of charge to the public at https://dsmblearningcenter.niaid.nih.gov. The modules include the following: an introduction to the objectives and purpose of Data Safety Monitoring Boards, the organization and responsibilities of Data Safety Monitoring Boards, and a review of statistical topics.

LIMITATIONS

The complex concepts that Data Safety Monitoring Board members must apply to their deliberations and decisions require practice and application that come through hands-on experience. To build competency in the Data Safety Monitoring Board member role, not only does a member need to understand these complex concepts but also the member must have the opportunity to practice and apply this knowledge to real-life situations. Additional resources to facilitate practice and application of the complex issues that Data Safety Monitoring Boards deal with should be considered. The computer-based training is targeted to new and inexperienced Data Safety Monitoring Board members. Ongoing learning opportunities should be developed for experienced Data Safety Monitoring Board members. Non-English training must also be considered.

CONCLUSION

The National Institute of Allergy and Infectious Diseases identified that training is not widely available for Data Safety Monitoring Board members to build the unique knowledge and skills necessary to serve on Data Safety Monitoring Boards. Consequently, National Institute of Allergy and Infectious Diseases developed publicly available web-based Data Safety Monitoring Board training modules for new or inexperienced members. Additional tools and resources are needed to help Data Safety Monitoring Board members acquire the knowledge and skills to serve their critical function in clinical research and to maximize research participant protections.

摘要

背景

数据安全监测委员会主要审查临床试验中不断积累的数据,并就是否应按计划继续、修改或终止方案向申办者提供建议。数据安全监测委员会通常根据只有其成员才能获取的积累数据提供建议。尽管数据安全监测委员会成员承担着重大责任,但文献中关于他们必须具备的独特知识以及因此为履行职责所需的培训内容需求的信息有限。

目的

本文描述了美国国立过敏与传染病研究所如何确定数据安全监测委员会成员应掌握的知识,以及该所开发的基于计算机的培训,以满足其组建的数据安全监测委员会成员的学习需求。

方法

美国国立过敏与传染病研究所进行了全面的文献检索,并采访了数据安全监测委员会的主题专家,包括来自学术机构、制药公司和美国国立卫生研究院的数据安全监测委员会成员及主席,以(1)评估数据安全监测委员会培训是否是已确定的需求,(2)评估是否已开发数据安全监测委员会培训,以及(3)制定合适的学习目标。基于从访谈中确定的学习目标开发了数据安全监测委员会培训模块。

结果

开发了三个数据安全监测委员会培训模块,并进行了基于网络访问的格式设置,公众可在https://dsmblearningcenter.niaid.nih.gov免费访问。这些模块包括以下内容:数据安全监测委员会的目标和目的介绍、数据安全监测委员会的组织和职责,以及统计主题回顾。

局限性

数据安全监测委员会成员在审议和决策中必须应用的复杂概念需要通过实践经验来掌握和应用。为了在数据安全监测委员会成员角色中建立能力,成员不仅需要理解这些复杂概念,还必须有机会将这些知识应用于实际情况。应考虑提供更多资源以促进对数据安全监测委员会处理的复杂问题的实践和应用。基于计算机的培训针对新的和缺乏经验的数据安全监测委员会成员。应为经验丰富的数据安全监测委员会成员开发持续学习机会。还必须考虑非英语培训。

结论

美国国立过敏与传染病研究所发现,数据安全监测委员会成员广泛缺乏培训,以培养在数据安全监测委员会任职所需的独特知识和技能。因此,美国国立过敏与传染病研究所为新的或缺乏经验的成员开发了公开可用的基于网络的数据安全监测委员会培训模块。还需要额外的工具和资源来帮助数据安全监测委员会成员获取知识和技能,以在临床研究中发挥其关键作用并最大限度地保护研究参与者。

相似文献

2
Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.
Clin Trials. 2011 Dec;8(6):727-35. doi: 10.1177/1740774511425181. Epub 2011 Oct 24.
3
4
American Society of Clinical Oncology policy statement: oversight of clinical research.
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
5
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
JBI Database System Rev Implement Rep. 2015 Jan;13(1):52-64. doi: 10.11124/jbisrir-2015-1919.
9
Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.
JBI Database System Rev Implement Rep. 2015 Oct;13(10):146-55. doi: 10.11124/jbisrir-2015-2150.
10
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.
Control Clin Trials. 1995 Dec;16(6):408-21. doi: 10.1016/s0197-2456(95)00073-9.

引用本文的文献

1
The evolving role of data & safety monitoring boards for real-world clinical trials.
J Clin Transl Sci. 2023 Aug 2;7(1):e179. doi: 10.1017/cts.2023.582. eCollection 2023.
3
Data Safety and Monitoring Boards Should Be Required for Both Early- and Late-Phase Clinical Trials.
JACC Basic Transl Sci. 2021 Nov 22;6(11):887-896. doi: 10.1016/j.jacbts.2021.09.005. eCollection 2021 Nov.
5
Interim monitoring in a treatment strategy trial with a composite primary endpoint.
Contemp Clin Trials. 2019 Nov;86:105846. doi: 10.1016/j.cct.2019.105846. Epub 2019 Sep 11.

本文引用的文献

1
Independent data monitoring committees: preparing a path for the future.
Am Heart J. 2014 Aug;168(2):135-41.e1. doi: 10.1016/j.ahj.2014.05.003. Epub 2014 May 15.
2
Data and safety monitoring boards: academic credit where credit is due?
JAMA. 2013 Oct 16;310(15):1563-4. doi: 10.1001/jama.2013.280383.
4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验